Branden Ryu

Company: Biorchestra Co. Ltd.

Job title: CEO and Scientific Founder

Seminars:

CNS Delivery of RNA Therapeutics Using LAT1 Target Polymeric Nanoparticle 11:00 am

Biorchestra Drug Delivery System (BDDSTM) is a proprietary technology utilizing non-lipid polymer ion complex and LAT1 targeting ligand for BBB penetration Preclinical assessment on ALS and Epilepsy of ASO therapeutics with BDDSTM technology BDDSTM technology is compatible with multiple RNA species with various lengths (e.g., ASO, siRNA & mRNA) and shows a therapeutic potency in…Read more

day: Conference Day One